Edgewise Therapeutics, Inc. EWTX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s total liabilities?
- Edgewise Therapeutics, Inc. (EWTX) reported total liabilities of $25.32M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s total liabilities changed year-over-year?
- Edgewise Therapeutics, Inc.'s total liabilities increased by 2.6% year-over-year, from $24.67M to $25.32M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s total liabilities has grown at a 47.5% compound annual growth rate (CAGR), from $4.34M to $30.35M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.